インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • アカデミックキー
  • ジャーナル目次
  • グローバル インパクト ファクター (GIF)
  • 中国国家知識基盤 (CNKI)
  • ウルリッヒの定期刊行物ディレクトリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • Google スカラー
このページをシェアする
ジャーナルチラシ
Flyer image

概要

The Synergy of Electrochemical Impedance Spectroscopy and Medicinal Technology

Edward P Randviir and Craig E Banks

A reversed phase high performance liquid chromatographic assay coupled with UV detection [239 nm] has been developed and validated for the determination of midazolam in rat plasma samples after transdermal administration. A liquid–liquid extraction was used to extract the compound from plasma sample. The separation was performed on a Hypersil ODS C18 column using a mobile phase composed of acetonitrile and 0.1% triethylamine aqueous solution [ 52:48, V/V], pumped at a flow rate 1.0 mL min-1. The calibration curves showed good linearity with correlation coefficient higher than 0.998 for all analytes in the range 0.10–10.0 μg mL-1. Accuracy in the measurement of quality control [QC] samples was in the range 95–107% of the nominal values. The intra-day and inter-day precisions in the measurement of QC samples were less than 10% coefficient of variation. The developed method is suitable for quality control of midazolam in their mixtures and in transdermal delivery system pharmaceutical preparations. The validated assay was found to be suitable for the pharmacokinetic study of midazolam in rats with transdermal administration.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません